Chromium and Insulin Aspart, a caution.
Chromium can improve glucose and insulin responses in some people with diabetes or insulin resistance. Added to insulin aspart, this may reduce insulin needs and increase the risk of hypoglycemia if meal doses are not adjusted. The risk is most relevant when chromium is started at high doses, diet changes at the same time, or glucose is already tightly controlled.
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Substances
- Chromium and Insulin Aspart
- Pair type
- Caution
- Evidence (highest tier)
- Moderate
- Source citations
- 3 sources
- Stack Score effect
- −5 to your Stack Score (per scored caution row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Caution · Moderate evidence
Caution
What is happening. Chromium can improve glucose and insulin responses in some people with diabetes or insulin resistance. Added to insulin aspart, this may reduce insulin needs and increase the risk of hypoglycemia if meal doses are not adjusted. The risk is most relevant when chromium is started at high doses, diet changes at the same time, or glucose is already tightly controlled.
Mechanism. Chromium may enhance insulin receptor signaling and improve peripheral glucose uptake in insulin-resistant states. This can add to insulin aspart's rapid stimulation of glucose uptake and suppression of hepatic glucose output after meals.
Recommendation. If you use insulin aspart, start chromium only with more frequent glucose checks. Monitor before meals, 2 hours after meals, and at bedtime for 1-2 weeks, and ask your diabetes clinician whether insulin-to-carbohydrate ratios or correction doses should change. Treat glucose below 70 mg/dL promptly.
Sources (3)
- Althuis MD, Jordan NE, Ludington EA, Wittes JT. Glucose and insulin responses to dietary chromium supplements: a meta-analysis. Am J Clin Nutr. 2002;76(1):148-155. PMID 12081828
- Singer GM, Geohas J. The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized trial. Diabetes Technol Ther. 2006;8(6):636-643. PMID 17109595
- Havel PJ. A scientific review: the role of chromium in insulin resistance. Diabetes Educ. 2004;Suppl:2-14. PMID 15208835
Stack Score
How this pair moves the number.
Effect on the composite score
If both Chromium and Insulin Aspart are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.